OBJECTIVE: To investigate the effect of subtotal petrosectomy and mastoid obliteration (SPMO) on the overall success of adult and pediatric cochlear implant (CI) recipients. STUDY DESIGN: Retrospective case series. SETTING: Tertiary care referral center. PATIENTS: Thirty-nine ears in 36 patients (23 adults and 13 children) received both surgeries between 1990 and 2012. INTERVENTION: CI candidates underwent SPMO to permit implantation and minimize the risks of infectious complications in the recipient ear. SPMO was performed before (69.3%), at the time of (25.6%), and after CI (5.13%). Mastoids were obliterated with fat (30.8%), muscle (66.7%), and bone pate (2.56%). MAIN OUTCOME MEASURE: Feasibility, complications, and success of SPMO and CI were assessed with standard statistical analysis and Fisher's exact test with 2-sided p values. RESULTS: Ear disease was definitively managed, and CI was successfully placed in all but one case. Complications including abscess (n = 3), subcutaneous emphysema (n = 1), ear canal granulation formation (n = 1), and electrode extrusion (n = 1) occurred in 15.4% of patients. Predisposing syndromes were present in children more often than adults (43.8% versus 13.0%, p = 0.0598). Adults more often than children had previous mastoid surgery for middle ear disease (30.4% versus 0.0%, p = 0.0288). CIs were placed under local anesthetic and sedation (n= 3) and after radiation treatment for nasopharyngeal cancer (n = 2) in adult ears. CONCLUSION: SPMO is an effective and safe procedure for definitively managing middle ear disease and implanting adult and pediatric CI candidates.
OBJECTIVE: To investigate the effect of subtotal petrosectomy and mastoid obliteration (SPMO) on the overall success of adult and pediatric cochlear implant (CI) recipients. STUDY DESIGN: Retrospective case series. SETTING: Tertiary care referral center. PATIENTS: Thirty-nine ears in 36 patients (23 adults and 13 children) received both surgeries between 1990 and 2012. INTERVENTION: CI candidates underwent SPMO to permit implantation and minimize the risks of infectious complications in the recipient ear. SPMO was performed before (69.3%), at the time of (25.6%), and after CI (5.13%). Mastoids were obliterated with fat (30.8%), muscle (66.7%), and bone pate (2.56%). MAIN OUTCOME MEASURE: Feasibility, complications, and success of SPMO and CI were assessed with standard statistical analysis and Fisher's exact test with 2-sided p values. RESULTS:Ear disease was definitively managed, and CI was successfully placed in all but one case. Complications including abscess (n = 3), subcutaneous emphysema (n = 1), ear canal granulation formation (n = 1), and electrode extrusion (n = 1) occurred in 15.4% of patients. Predisposing syndromes were present in children more often than adults (43.8% versus 13.0%, p = 0.0598). Adults more often than children had previous mastoid surgery for middle ear disease (30.4% versus 0.0%, p = 0.0288). CIs were placed under local anesthetic and sedation (n= 3) and after radiation treatment for nasopharyngeal cancer (n = 2) in adult ears. CONCLUSION: SPMO is an effective and safe procedure for definitively managing middle ear disease and implanting adult and pediatric CI candidates.
Authors: Burkard Schwab; Eugen Kludt; Hannes Maier; Thomas Lenarz; Magnus Teschner Journal: Eur Arch Otorhinolaryngol Date: 2015-06-20 Impact factor: 2.503
Authors: Ignacio Arístegui; Gracia Aranguez; José Carlos Casqueiro; Manuel Gutiérrez-Triguero; Almudena Del Pozo; Miguel Arístegui Journal: Audiol Res Date: 2022-02-25